Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

CLSD

Clearside Biomedical Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

CLSD:Clearside Biomedical Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$1.30

EXCHANGE

NASDAQ

SECTOR

Health Care

CLSD
Clearside Biomedical Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
CLSD
Clearside Biomedical Inc Stock Information
Latest Close Price$1.30
52-Week Low/High$1.31 - $15.33
Percent Held by Institutions0.00%
Revenue$55,000
Net Income$-101,545,000
Cash Flow$-19,719,000
EPS-0.75%
Market Cap$41,631,200
PE Ratio0
PE Ratio to Industry65%
Debt-Equity Ratio22.00%
Debt-Equity to Industry1.39%
Total Return Last 12 Months-79.69%
Total Return Last 3 Years0.00%
Total Return Last 5 Years0.00%
Latest Trade DateDec. 13, 2018
CLSD
Clearside Biomedical Inc Dividend Payment History

No Data available for Payment History.

CLSD
Clearside Biomedical Inc Other Details

Clearside Biomedical is a late-stage clinical biopharmaceutical company developing pharmacological therapies to treat blinding diseases of the eye. Co.'s existing product candidates focus on diseases affecting the retina, which is the tissue that lines the inside of the eye and is primarily responsible for vision, and the choroid, which is the layer adjacent to the retina that supplies the retina with blood, oxygen and nourishment. Co. is also developing CLS-TA along with an anti- vascular endothelial growth factor agent for the treatment of macular edema associated with retinal vein occlusion, a sight-threatening disorder resulting from the blockage of a retinal vein.

Web Sitewww.clearsidebio.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Clearside Biomedical Inc Dividend Stock News and Updates

Dec. 05, 2018CLOSE PRICE DECREASE: Clearside Biomedical Inc (NASDAQ: CLSD) on 12-05-2018 decreased close price > 10% from $1.52 to $1.36

Read more...

Nov. 28, 2018CLOSE PRICE DECREASE: Clearside Biomedical Inc (NASDAQ: CLSD) on 11-28-2018 decreased close price > 10% from $1.73 to $1.52

Read more...

Nov. 13, 201852 WEEK LOW: Clearside Biomedical Inc (NASDAQ: CLSD) on 11-13-2018 hit a 52 week low of $1.72

Read more...
More Clearside Biomedical Inc Dividend News
Pharmaceuticals Dividend Stock News and Updates

Dec. 14, 2018CLOSE PRICE INCREASE: Acusphere Inc (OTCBB: ACUS) on 12-14-2018 increased close price > 10% from $0.02 to $0.05

Read more...

Dec. 14, 2018CLOSE PRICE INCREASE: Biostar Pharmaceuticals Inc (OTCBB: BSPM) on 12-14-2018 increased close price > 10% from $0.40 to $0.60

Read more...

Dec. 14, 2018CLOSE PRICE DECREASE: China BCT Pharmacy Group, Inc. (OTCBB: CNBI) on 12-14-2018 decreased close price > 10% from $0.00 to $0.00

Read more...
More Pharmaceuticals Dividend News
FREE REPORT
X
Bryan Perry Dividend Income Expert Bryan Perry

Earn 8% on this "Government Mandated Income Opportunity"

X

Search Dividend Investor